arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Zymeworks Inc.

ZYME

$23.52 ▲ +0.34 (+1.47%) at close

7 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Zymeworks Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.8B

Dividend Yield —

Revenue Growth 38.9% ↗

Op. Margin -87.3% ↗

ROIC -35.1% ↗

FCF / Share $-0.46 ↗

Trailing P/E —

Price / Book 6.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$105.97M

↑ +38.9% —

Net Income Profit after all expenses

$-81.13M

↑ +33.9% —

Operating Margin Operating profit as % of sales

-87.3%

↑ +51.4% 3th

FCF / Share Free cash flow per share

$-0.46

↑ +69.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	38.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+386%)	0.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-95%)	-81.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1120%)	1446.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17975%)	-31.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-494%)	—	—
EPS Growth YoY (%)	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	5.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-14.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	33.9% Excellent Excellent Year-over-year change in net income	-3.4% Weak Weak Year-over-year change in net income	N/M	N/M	-17.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	69.0% Excellent Excellent Year-over-year change in free cash flow	15.8% Good Good Year-over-year change in free cash flow	N/M	N/M	-28.6% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-36.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	41.9% Excellent Excellent Compound annual revenue growth over 3 years	25.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	22.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-87.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-682%)	-179.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1298%)	-181.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1311%)	31.6% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+111%)	—	-481.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3309%)	—
Effective Tax Rate (%) (%)	-1.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-76.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-738%)	-160.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1440%)	-156.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1401%)	30.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+151%)	—	-463.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3963%)	—
FCF Margin (%) (%)	-32.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-146.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-158.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	33.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	-399.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-35.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	24.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-86.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-45.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	20.1% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	-55.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-30.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-36.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-341%)	-25.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-270%)	25.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+68%)	-85.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-667%)	-44.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-394%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-41.16M	$-66.10M	$-157.56M	$-400.91M	$-201.87M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$1.41	$1.01	$1.10	$6.33	$0.52	$0.77	—
Basic EPS, GAAP (USD)	$-1.08	$-1.62	$-1.72	$1.91	$-4.11	$-3.58	—
Free Cash Flow per Share (USD)	$-0.46	$-1.48	$-1.75	$2.09	$-3.97	$-3.09	—
Book Value per Share (USD)	$3.60	$4.91	$6.63	$7.82	$5.34	$8.14	—
Tangible Book Value per Share (USD)	$3.44	$4.74	$6.46	$7.63	$5.08	$8.14	—
Basic Weighted Avg Shares (shares)	75.40M	75.85M	68.86M	65.19M	51.55M	50.38M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$206.45M	$212.16M	$357.16M	$449.08M	$216.37M	—	—
Total Equity (USD)	$268.50M	$338.77M	$464.81M	$492.96M	$249.09M	$409.92M	$245.68M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$105.97M	$76.30M	$76.01M	$412.48M	$26.68M	$38.95M	—
Depreciation Expense (USD)	$3.67M	$4.19M	$7.46M	$6.22M	$3.74M	$3.35M	—
Net Income, GAAP (USD)	$-81.13M	$-122.69M	$-118.67M	$124.34M	$-211.84M	$-180.55M	—
Operating Cash Flow (USD)	$-33.01M	$-110.06M	$-118.30M	$144.11M	$-192.45M	$-151.40M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 23 quarters

Zymeworks Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ZYME with peers